 | |
| Discipline | Epigenomics |
|---|---|
| Language | English |
| Edited by | James G. Herman, Jörg Tost |
| Publication details | |
| History | 2009–present |
| Publisher | Future Medicine Ltd |
| Frequency | Monthly |
| Impact factor | 4.778 (2020) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Epigenomics |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| CODEN | EPIGC7 |
| ISSN | 1750-1911 (print) 1750-192X (web) |
| OCLC no. | 746948365 |
| Links | |
Epigenomics is a peer-reviewed medical journal established in 2009 and published by Future Medicine. The editors-in-chief are James G. Herman (University of Pittsburgh Cancer Institute) and Jörg Tost (Centre national de génotypage [fr]). The journal covers all aspects of research on epigenomics and epigenetics and their implications for diagnosis, prognosis and therapeutics.
Abstracting and indexing
The journal is abstracted and indexed in EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Chemical Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2017 impact factor of 4.979, ranking it 31st out of 166 journals in the category "Genetics & Heredity".
References
- "Journals Ranked by Impact: Genetics & Heredity". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.